If found in any preneoplastic lesions, this gene's methylation should point to highly carcinogenic lesions that need to be addressed and monitored aggressively due to its implication with major cancer pathways, including VEGF that points to metastasis implications as well as NKX6-2 gene located on chromosome 10, known as a prognostic marker. This evidence concerns the gene NKX6-2 and cancer.